In September 2014, two families 500 miles apart were hit with the most devastating news imaginable.

Both families had a son diagnosed with the deadliest form of pediatric brain cancer and given just 9 months to live. Tammi and Jason Carr, in Michigan, and Jenny and Mark Mosier, in Maryland, began a journey through the darkest days of their lives. By the end of the following year, the families had endured the inevitable heartbreaking loss of their sons, Chad Carr, age 5, and Michael Mosier, age 6, to diffuse intrinsic pontine glioma (DIPG).

The Carrs and Mosiers share a passion for honoring their sons by changing the outlook for future families forced to face the horror of DIPG. Both families established foundations to find a cure for DIPG. In 2021, those foundations united to form the ChadTough Defeat DIPG Foundation, becoming the leading force to defeat DIPG.

The Carrs and Mosiers are now joined by a growing, international team of passionate Family Partners who are committed to changing the outcome for future families facing DIPG/DMG, in honor of their children.

While the survival rate for DIPG is still nearly 0%, doctors now believe a cure for DIPG is within reach. The ChadTough Defeat DIPG research program is guided by a Scientific Advisory Council made up of the leading experts in the field. The foundation will continue to be a part of this fight until DIPG is no longer a death sentence.